30 Participants Needed

tDCS + Speech Therapy for Aphasia

Recruiting at 1 trial location
ES
Overseen ByE. Susan Duncan, PhD, CCC-SLP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Louisiana State University and A&M College
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether combining speech therapy with transcranial direct current stimulation (tDCS) can aid individuals with chronic aphasia, a language disorder often caused by a stroke. Participants will receive either real or sham tDCS alongside their therapy to determine if the real stimulation enhances language recovery. Individuals who experienced a left hemisphere stroke over six months ago and have been diagnosed with aphasia may qualify, provided they have not recently undergone other speech therapy and can attend 16 sessions over 8 weeks. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve language recovery options for future patients.

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a history of seizures or have changed seizure medication in the past 12 months, you may be excluded from participating.

What prior data suggests that transcranial direct current stimulation (tDCS) is safe for use in aphasia therapy?

Research has shown that transcranial direct current stimulation (tDCS) is generally safe and well-tolerated in human trials. Studies indicate that standard tDCS methods (up to 40 minutes, 4 milliamps) have not caused any serious side effects. This treatment is noninvasive and not painful, making it a promising option for helping people with aphasia recover language skills after a stroke.

Speech-language therapy (SLT) is a common and safe method for improving speech and language skills in people with aphasia. When combined with tDCS, this therapy might offer even greater benefits without major safety concerns.

Overall, research supports the safety of both tDCS and SLT, providing a strong basis for their use in clinical settings.12345

Why are researchers excited about this trial?

Researchers are excited about using transcranial direct current stimulation (tDCS) combined with speech therapy for aphasia because it offers a novel approach compared to traditional speech-language therapy alone. Unlike standard treatments that primarily focus on rehabilitating language skills through practice and exercises, tDCS involves applying a mild electrical current to specific brain areas, potentially enhancing the brain's ability to repair and reorganize itself. This technique could speed up recovery and improve outcomes by stimulating brain regions involved in speech and language. Additionally, the use of a sham comparator allows researchers to assess the true efficacy of tDCS, helping to distinguish its benefits from the placebo effect.

What evidence suggests that this trial's treatments could be effective for aphasia?

This trial will compare the effects of anodal transcranial direct current stimulation (A-tDCS) combined with speech-language therapy (SLT) to a sham version of tDCS combined with SLT. Studies have shown that using a gentle electrical treatment like A-tDCS with SLT can aid people with language problems after a stroke. Research suggests this combination might enhance their ability to speak and repeat words. Some studies indicate that the electrical treatment in tDCS can enhance traditional language therapy. However, other studies have mixed results, with some showing no significant difference when comparing A-tDCS to a sham version. Overall, while the results are promising, they vary, so more research is needed to confirm its effectiveness.13567

Who Is on the Research Team?

ES

E. Susan Duncan, PhD, CCC-SLP

Principal Investigator

City University of New York

Are You a Good Fit for This Trial?

This trial is for right-handed, English-speaking adults with a high school education who had a single-event left hemisphere stroke over 6 months ago and have chronic aphasia. They must not be receiving other speech therapies during the study or have any conditions that would interfere with MRI scans, such as metal implants or pregnancy.

Inclusion Criteria

I can do the tasks needed for therapy, even with my speech difficulties.
High school education or equivalent
I can do the speaking and MRI tasks needed for the study.
See 5 more

Exclusion Criteria

I haven't had seizures or changed seizure medication in the last year.
You have a hairstyle that prevents electrodes from touching your scalp.
Failed vision or hearing screening
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person), 1 visit (virtual)

Pre-Treatment Assessment

Participants complete behavioral assessments and brain scans before therapy

4 weeks
2 visits (in-person)

Treatment

Participants receive tDCS and aphasia therapy for 8 weeks

8 weeks
16 visits (in-person)

Post-Treatment Assessment

Behavioral assessments and brain scans are conducted immediately after therapy

1 week
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

8 weeks
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Anodal transcranial direct current stimulation
  • Sham transcranial direct current stimulation
  • Speech-Language Therapy (SLT)
Trial Overview The study tests if brain stimulation using transcranial direct current stimulation (tDCS) can improve language abilities in people with post-stroke aphasia when combined with verb network strengthening treatment (VNeST). Participants receive weak electrical currents to their scalp twice weekly for 8 weeks during speech therapy sessions.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: A-tDCS & speech-language therapyExperimental Treatment2 Interventions
Group II: Sham-tDCS & speech-language therapyPlacebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Louisiana State University and A&M College

Lead Sponsor

Trials
12
Recruited
1,100+

City University of New York

Lead Sponsor

Trials
23
Recruited
6,000+

Published Research Related to This Trial

In a study involving 10 individuals undergoing standard aphasia therapy, 70% expressed interest in and were eligible for transcranial direct current stimulation (tDCS), which was administered during therapy sessions.
Data from four participants showed a large effect size (Cohen's d = 1.32) favoring active tDCS over sham stimulation, suggesting that tDCS may enhance communication outcomes in aphasia therapy, although one participant with severe deficits did not benefit.
Clinical Feasibility of Combining Transcranial Direct Current Stimulation with Standard Aphasia Therapy.Duncan, ES., Nakkawita, SG.[2022]
A systematic review of 12 trials involving 136 participants found no evidence that transcranial direct current stimulation (tDCS) improves functional communication or language impairment in stroke patients with aphasia.
The meta-analysis of six trials indicated that tDCS did not significantly enhance outcomes in picture naming tasks, suggesting that it may not be an effective adjunct to speech and language therapy for aphasia.
Transcranial direct current stimulation (tDCS) for improving aphasia in patients with aphasia after stroke.Elsner, B., Kugler, J., Pohl, M., et al.[2022]
A systematic review of five trials with 54 participants found no evidence that transcranial direct current stimulation (tDCS) improves speech and language therapy outcomes for stroke patients with aphasia.
While no adverse events were reported, the studies primarily measured picture naming rather than real-life communication, and cathodal tDCS over the non-lesioned hemisphere showed potential as a promising approach.
Transcranial direct current stimulation (tDCS) for improving aphasia in patients after stroke.Elsner, B., Kugler, J., Pohl, M., et al.[2022]

Citations

Effect of transcranial direct current stimulation combined ...tDCS combined with SLT demonstrates potential enhancement in language recovery on post-ischemic stroke aphasia. The combination may augment speech content, ...
Effectiveness of Transcranial Direct Current Stimulation as ...All SRs and one MA reported improvements following tDCS stimulation for general aphasia abilities and measures of repetition and speech fluency.
Transcranial direct current stimulation (tDCS) for improving ...Currently there is no evidence of the effectiveness of tDCS (anodal tDCS, cathodal tDCS and Dual‐tDCS) versus control (sham tDCS) for improving functional ...
Transcranial Direct-Current Stimulation in Subacute AphasiaThis single-center, randomized, double-blind, sham-controlled efficacy trial tested the hypothesis that anodal tDCS augments language therapy in subacute ...
Transcranial Direct Current Stimulation and Aphasia ...The purpose of this study is to evaluate the effectiveness of small amounts of electrical current, applied without surgery to the brain, in combination with ...
Safety of transcranial Direct Current Stimulation: Evidence ...To date, the use of conventional tDCS protocols in human trials (≤40 min, ≤4 mA, ≤7.2 Coulombs) has not produced any reports of a Serious Adverse Effect or ...
Transcranial Direct Current Stimulation and Aphasia ...This study proposes to evaluate the safety, feasibility, and effectiveness of anodal and cathodal tDCS in study subjects with Broca's aphasia after stroke, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security